Prostatic fatty acids and cancer recurrence after radical prostatectomy for early-stage prostate cancer

Cancer Causes Control. 2007 Mar;18(2):211-8. doi: 10.1007/s10552-006-0095-6. Epub 2007 Jan 9.

Abstract

Objective: Results from some observational studies suggest that diet and energy balance influence the clinical course of early-stage prostate cancer. To evaluate possible mechanisms, we prospectively examined the relation between prostatic concentrations of fatty acids at diagnosis and cancer recurrence following primary therapy.

Methods: Fatty acids were measured by capillary gas chromatography in fresh, non-cancerous prostate tissue collected from 184 men undergoing radical prostatectomy for clinically localized prostate cancer. Their association with risk of biochemical disease recurrence (a rising serum prostate-specific antigen following a disease-free [<0.1 ng/ml] interval > or =6 months) was analyzed using Cox proportional hazards models incorporating patient age, body mass index, tumor characteristics at diagnosis, and ethnicity.

Results: During an average follow-up of 48.7 months (median = 47), 14 patients experienced biochemical recurrence. Percent total polyunsaturated fatty acid and the ratio of oleic-to-stearic acid associated with risk (multivariable hazards ratio [HR] = 0.51, 95% confidence interval [CI] = 0.29 to 0.90, p = 0.021 and HR = 1.68, 95% CI = 1.21 to 2.33, p = 0.002, respectively, per 1 standard deviation increase).

Conclusions: The results of this study are preliminary, but they suggest that pre-diagnostic prostatic concentrations of fatty acids associate with risk of biochemical recurrence following radical prostatectomy for clinically localized prostate cancer.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Black or African American
  • Body Mass Index
  • Cohort Studies
  • Disease-Free Survival
  • Fatty Acids / analysis*
  • Humans
  • Illinois / epidemiology
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / chemistry*
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm Staging
  • Prognosis
  • Proportional Hazards Models
  • Prostate / chemistry*
  • Prostate-Specific Antigen / blood
  • Prostatectomy
  • Prostatic Neoplasms / chemistry*
  • Prostatic Neoplasms / epidemiology
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / surgery
  • Risk
  • White People

Substances

  • Fatty Acids
  • Prostate-Specific Antigen